Mechanism of atropine-resistant atrioventricular block during inferior myocardial infarction: possible role of adenosine
RC Wesley Jr,
BB Lerman,
JP DiMarco,
RM Berne,
and
L Belardinelli
Mechanisms responsible for atrioventricular (AV) block during acute inferior myocardial infarction are only partially understood. Increased parasympathetic tone is the factor usually postulated; however, persistence of AV block after atropine administration is frequently observed. Adenosine, an endogenous ischemic metabolite, has well established depressant effects on AV node conduction. In this report, an episode of atropine-resistant AV block was reversed by aminophylline, a competitive adenosine antagonist, in a patient with an acute inferior myocardial infarction. This observation suggests a role for adenosine in the mediation of ischemia-induced AV node block.
This article has been cited by other articles:

|
 |

|
 |
 
N. Kakouros and D. V. Cokkinos
Right ventricular myocardial infarction: pathophysiology, diagnosis, and management
Postgrad. Med. J.,
December 1, 2010;
86(1022):
719 - 728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. RuDusky
Aminophylline: Exploring Cardiovascular Benefits Versus Medical Malcontent
Angiology,
May 1, 2005;
56(3):
295 - 304.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kirchhof, L. Fabritz, L. Fortmuller, G. P. Matherne, A. Lankford, H. A. Baba, W. Schmitz, G. Breithardt, J. Neumann, and P. Boknik
Altered sinus nodal and atrioventricular nodal function in freely moving mice overexpressing the A1 adenosine receptor
Am J Physiol Heart Circ Physiol,
June 5, 2003;
285(1):
H145 - H153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Goldstein
Pathophysiology and management of right heart ischemia
J. Am. Coll. Cardiol.,
September 4, 2002;
40(5):
841 - 853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. G. Lurie, A. Sugiyama, S. McKnite, P. Coffeen, K. Hashimoto, and S. Motomura
Modulation of AV nodal and Hisian conduction by changes in extracellular space
Am J Physiol Heart Circ Physiol,
March 1, 1999;
276(3):
H953 - H960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Brignole, G. Gaggioli, C. Menozzi, L. Gianfranchi, A. Bartoletti, N. Bottoni, G. Lolli, D. Oddone, D. Attilio Del Rosso, and G. Pellinghelli
Adenosine-Induced Atrioventricular Block in Patients With Unexplained Syncope : The Diagnostic Value of ATP Testing
Circulation,
December 2, 1997;
96(11):
3921 - 3927.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. D. Bertolet, L. Belardinelli, E. A. Franco, W. W. Nichols, R. A. Kerensky, and J. A. Hill
Selective Attenuation by N-0861 (N6-Endonorboran-2-yl-9-Methyladenine) of Cardiac A1 Adenosine Receptor Mediated Effects in Humans
Circulation,
May 15, 1996;
93(10):
1871 - 1876.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. D. Bertolet, E. B. McMurtrie, J. A. Hill, and L. Belardinelli
Theophylline for the Treatment of Atrioventricular Block after Myocardial Infarction
Ann Intern Med,
October 1, 1995;
123(7):
509 - 511.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. L. Dattilo, C. E. Eiriksson Jr, and R. E. Vestal
Increased Ventricular Response Rate During Exercise in Patients With Atrial Fibrillation Treated With Theophylline
Arch Intern Med,
April 1, 1992;
152(4):
797 - 803.
[Abstract]
[PDF]
|
 |
|
|